Skip to main content

Our research

Cancer remains one of the greatest challenges to the EU healthcare systems. Early detection and diagnosis dramatically increases the prospect of successful treatment and survival. Academia and the rapidly growing cancer diagnostics and biosensors sectors have an urgent need for researchers skilled in developing improved screening technologies, which can offer major opportunities to impact cancer survival. However, the development of assays with the required sensitivity, reliability and technology formats for multi-cancer early detection is only recently emerging and faces significant R&D challenges.

STRIM trains a cohort of researchers in the multi-disciplinary science, bioinformatics, technology, social, clinical and healtheconomic skills required to deliver comprehensive bioelectronic tools for cancer screening, tools that are fast, accurate, sensitive, and exploit advanced molecular receptors and nanobiotechnologies for detection of aberrant post-translational modifications (PTM) of proteins and nucleic acids as cutting-edge biofluid markers for early detection of cancers. Growing evidence suggests that PTM play important roles in human cancers and are likely to prove highly specific for cancer type. Focusing on both genomic and proteomic PTM biomarkers will be a game-changing strategy for improving early cancer detection rates, efficiency and population health.

Hall of fame

DC1 Project

Electrocatalytic microarray biosensors for early diagnosis and prognosis of cancer

Description

The aim of this project is the development of specific multiplex PTM biosensors for early clinical detection of cancer and its state through liquid biopsy testing and validate them with clinical samples. The DC will construct innovative microarray aptamer and DNA electrodes with improved antifouling properties based on electrocatalytic beacons for free and glycosylated proteins and nucleic acids mis-regulated in breast, prostate, gastric and colorectal cancers and adapt them for microfluidic multiplex sensing of cancer signatures in cancer patients.

Research fields: Electrochemistry, Surface Science, Biochemistry, Biotechnology, Molecular Biology

Main Supervisor: Elena Ferapontova (elena.ferapontova@inano.au.dk)

Host Institution:

Giuseppina Rea, M.Sc.

My name is Giusy and I am originally from Italy, I obtained my Master’s Degree in Pharmacy at University Federico II of Naples. During my studies I developed a strong Interest in the field of analytical chemistry particularly through my thesis project conducted at the UniNanobiosensors Lab, focusing on the development of biosensors to detect and quantify miRNA encapsulated in lipid nanoparticles. This laboratory experience inspired me deeply and solidified my interest in innovative diagnostic technologies. In August 2025 I began my PhD at Aarhus University as part of the STRIM network. My research focus on developing advanced detection systems for post-transcriptional modifications that may contribute to early diagnosis of cancer. I am thrilled to be part of this interdisciplinary and international network, where I aim to contribute to advance biosensor technologies to improve early cancer diagnosis and patient outcomes.

DC2 Project

Electrocatalytic approaches to high sensitivity PTM detection of cancer metastatic state and its therapy efficacy

Description

This project develops and analytically and clinically validates bioelectronic assays on magnetic beads (MB) for accurate monitoring of therapy efficacy in patients with metastatic breast, prostate, gastric and colorectal cancers. The DC will develop electrochemical ELASA on MBs with novel electrocatalytic labels and apply them for liquid biopsy analysis of cancer patients’ samples for PTM of selected proteins. Assays will be integrated within the bioelectronic MB-based strip test device for PoC monitoring of the cancer treatment efficacy and characterizing the type of tumor and resistance to treatment

Research fields: Electrochemistry, Surface Science, Biochemistry, Biotechnology, Molecular Biology

Main Supervisor: Elena Ferapontova (elena.ferapontova@inano.au.dk)

Host Institution:

Yingxi Long, M.Sc.

My name is Yingxi Long; you can call me Sissie, and I am from China. I obtained my master’s degree in biological sciences and my bachelor’s degree in biomedical engineering from the Chinese University of Hong Kong. My master’s project focused on biosensor development and fabrication for various biomarker detection. There, I acquired interdisciplinary knowledge, including the synthesis and modification of micro- and nanomaterials, molecular biology, and electrochemistry. Throughout my research, I contributed to the transformation of experimental results into research articles, where I participated in the publication of five research papers in the fields of biotechnology and biosensors, covering topics such as multiplexed protein detection and cervical cancer screening using paper-based microfluidics, as well as the development of optical sensors integrated with nucleic acid amplification technologies. Through continuous practice and learning, I have developed a strong interest in developing transformable biosensors for point-of-care cancer detection. I am excited to join the STRIM project, where I am responsible for developing clinically validated bioelectronic assays on magnetic beads targeting PTM biomarkers for real-time cancer monitoring. I look forward to collaborating with other scientists to develop an innovative platform for early multi-cancer detection..

DC3 Project

Ultrasensitive detection of Methylated DNA cancer biomarkers by direct (label free) electrochemiluminescence

Description

The aim of this project is to create a multianalyte, multi-replicate, multianalyte device for measuring PTM biomarkers with ECL detection. In particular, to create novel ECL luminophore dyes for labelling aptamers and antibodies enabling multiplexed assays with target discrimination; to develop highly sensitive ECL assays for methylated DNA and proteins with aberrant glycosylation patterns; to test the analytical performance of the assays using serum samples collected from patients to integrate the assays within a 384 microwell electrode array and determine the performance required from an optical reader to identify the feasibility of using a mobile phone camera as the detector.

Research field: Electrochemistry, Surface Science, Biochemistry, Molecular Biology

Main Supervisor(s): Robert Forster (Robert.Forster@dcu.ie)

Host Institution:

Ewa Bieniasz, M.Sc.

My name is Ewa, and I am originally from Poland. I obtained my Bachelor’s degree in Chemistry and Forensic Toxicology at the University of Wroclaw, followed by a Master’s degree in Radiogenomics at the University of Warsaw. During my studies, I developed a strong interest in electrochemistry and chemical sensors, which began during my Erasmus+ internship at the University of Ljubljana. There, I worked on the development of a voltammetric sensor for microplastic detection, combining environmental and analytical chemistry. This experience led me to join the research team at Malmö University in Sweden, where I contributed to a project focused on electrochemical sensors for detecting pregnancy hormones.In April 2025, I started my PhD as part of the Marie Skłodowska-Curie STRIM Network, under the supervision of Professor Forster. My research focuses on developing ultrasensitive biosensors for the detection of methylated DNA cancer biomarkers using direct electrochemiluminescence. I am excited to be part of this interdisciplinary and international network, where I can further explore sensor technologies with impactful applications in early cancer detection.

DC4 Project

High throughput multi-analyte microfluidics devices for PTM based screening

Description

This project aims to create ECL luminophore – nanoparticle (NP) pairs where a fraction of the ECL generated activates the plasmon of metal NP, generating an intense electric field that amplifies the ECL generated by the other luminophores immobilised on NP, and to develop new approaches for the deposition of aptamer and antibody receptors onto individual electrodes and within microwell electrode arrays. The objective is to establish high performance antibody based ECL assays for methylated DNA and test the assay performance using real patient samples.

Research field: Electrochemistry, Surface Science, Biochemistry, Molecular Biology

Main Supervisor(s): Robert Forster (Robert.Forster@dcu.ie)

Host Institution:

Francesco Petrini, M.Sc.

My name is Francesco, and I am originally from Italy. I obtained my Bachelor’s Degree in Chemistry and Material Chemistry at the University of Bologna. During my studies, I joined the Erasmus+ Traineeship and worked at Wageningen University and Research in the BioNanoTechnology group, where I developed a 3D-printed cell for electrochemiluminescence experiments and learned the fundamentals of microfluidics. I received my Master’s Degree in Photochemistry and Molecular Materials at the University of Bologna in September 2025, after spending five months as an Erasmus+ Traineeship intern at Université Paris Cité in the PIXEL group, where I investigated electrochemiluminescence mechanisms through finite element simulations on a novel system designed for ECL generation. These experiences and the focus of my studies sparked my interest in electrochemiluminescence and its cutting-edge applications for detecting and quantifying biomarkers linked to diverse pathological conditions, including cancer, infectious diseases, autoimmune disorders, and cardiac events. I will begin my PhD as part of the Marie Skłodowska-Curie STRIM Network, under the supervision of Professor Forster, in October 2025. My research will focus on developing a high-throughput multi-analyte microfluidics device for the detection of methylated DNA cancer biomarkers, giving me the opportunity to combine the various techniques I explored throughout my two traineeships. I am excited to be part of such an international and interdisciplinary doctoral network, where I will collaborate with other scientists to develop an innovative multiplexing device to be tested on real patient samples.

DC5 Project

Targeting aberrant O-glycosylation with aptamers for cancer diagnostics

Description

The aim of this PhD project is the selection and characterization of aptamer receptors for the O-glycosylation site of glycoproteins, such as mucins, overexpressed in colorectal cancer, and their application to develop diagnostic tools for early detection of cancer. The DC will select the aptamers and will design and optimize sensing platforms using them to detect aberrant glycosylated forms of the selected proteins, evaluating their diagnostic potential by testing clinical samples.

Research field: Electrochemistry, Surface Science, Biochemistry, Molecular Biology

Main Supervisor(s): María Jesús Lobo-Castañón (mjlc@uniovi.es) and Noemí de-los-Santos-Álvarez (santosnoemi@uniovi.es) 

Host Institution:

Alessandra Martucci, M.Sc.

My name is Alessandra Martucci, and I am an Italian biologist and registered nutritionist with a strong passion for translational research. I earned my MSc with honors in Human Nutrition from the University of Naples Federico II, where I explored the intersection of nutrition, immunology, and oncology. During my academic journey, I completed a thesis internship at the Institute of Endocrinology and Molecular Oncology (IEOMI-CNR) in Naples, gaining hands-on experience in molecular and cellular biology. A subsequent traineeship in Canada allowed me to deepen my skills in proteomic and bioinformatic analyses within an international research environment. Following graduation, I was awarded a post-graduate research fellowship at the University Hospital Federico II, further enhancing my clinical and research competencies. These experiences have solidified my commitment to advancing knowledge in molecular oncology. I am eager to join the MSCA PhD program, where I can contribute my expertise and continue to grow within a dynamic and interdisciplinary research community.

DC6 Project

Aptamer microarrays for glycoprofiling of cancer biomarkers

Description

This PhD project aims to obtain and characterize a panel of aptamers mimicking lectins to recognize aberrant glycosylation patterns of proteins, using them to develop aptamer microarrays and other platforms for profiling specific N-linked glycoforms of protein biomarkers. The DC will evaluate differential glycoforms of selected glycoproteins, such as carcinoembryonic antigen, in colorectal tumor tissues and normal tissues, assessing their diagnostic/prognostic performance in serum samples.

Research field: Electrochemistry, Surface Science, Biochemistry, Molecular Biology

Main Supervisor(s): María Jesús Lobo-Castañón (mjlc@uniovi.es) and Rebeca Miranda Castro (mirandarebeca@uniovi.es)

Host Institution:

Desiré Rivera Borges, M.Sc.

I am Desiré Rivera Borges, a chemical engineer from the island of Puerto Rico with a passion for research, science communication, and education accessibility. During my academic career, I obtained my Chemical Engineering Bachelor’s degree at the University of Puerto Rico – Recinto Universitario de Mayagüez, where I contributed to an on-campus research project for two years and completed four summer research internships across academic and industrial laboratories in the United States. These projects spanned topics including biomaterials, neurological biosensors, CarT cell therapy, cancer tumor stiffness, oligonucleotide synthesis, and protein fermentation. Additionally, I have 18 months of work experience as a process engineer in the biopharmaceutical industry. I have also led two volunteer groups in my community: one group ensured food security for university students, while the other developed nuclear science communication and education programs. As the Marie Skłodowska-Curie STRIM Network’s translational objectives align with my own, I am eager to contribute to advances in cancer screening technologies as I complete my PhD under the guidance of Dr. María Jesús Lobo-Castañón at the University of Oviedo.

DC7 Project

Stable bioelectrodes for ultrasensitive electrochemical sensors

Description

The aims of this project are (i) the development of femto-second laser ablation technology for surface nano-patterning of gold electrodes in the biosensor microarray for electrochemical cancer detection; (ii) creation of nano-patterned PEDOT electrodes in the biosensor microarray for electrochemical cancer detection by soft nano-imprint of photo-curable PEDOT formulation. The surface nano-pattern will be optimized to achieve antifouling properties and long-life time of Au electrodes for electrochemical sensors. The photo-curable PEDOT formulation and characteristics of the surface nano-pattern will be adjusted for improved antifouling properties and long-life time of the polymeric electrodes. The nano-patterned gold electrodes and nano-patterned polymeric electrodes will be fabricated and tested with assays developed by the STRIM partners.

Research field: Physics, Laser Physics, Nanoscience, Electrochemistry, Surface Science, Biochemistry, Molecular Biology

Main Supervisor(s): Prof. Dr. Boris Chichkov (chichkov@iqo.uni-hannover.de)

Host Institution:

Ma’ruf Mamanazarov, M.Sc.

My name is Ma’ruf, and I’m originally from Uzbekistan. I obtained my Bachelor’s degree in Physics at the Termez State University and my Master’s degree in Physics at the National University of Uzbekistan named after Mirzo Ulugbek. I have 20 months of experience as a nanotubes and graphene nanomaterials researcher at the Arifov Institute of Ion-Plasma and Laser Technologies of the Academy of Sciences of the Republic of Uzbekistan. During my academic career, I attended summer research internships and workshops at the ETH Zurich and the University of Cambridge. There, I investigated the unique fast-forward of dynamics of nanosystems, laser ablation techniques and laser light absorption in condensed matter and materials, integrating numerical simulations on innovative systems developed for nanomaterials. My research will focus on advancing femtosecond laser ablation techniques for nanopatterning gold electrode surfaces and on developing nanopatterned PEDOT electrodes for biosensor microarrays aimed at electrochemical cancer detection, building on the experience gained during my two previous experiences. My PhD in the Marie Skłodowska-Curie STRIM Network, under the supervision of Professor Chichkov. Specifically, my research will continue to improve upon femtosecond laser ablation for nanopatterning, especially of gold electrode surfaces, and the production of these nanopatterned PEDOT electrodes in biosensor microarrays targeting electrochemical cancer detection. I am excited to be part of such an international and interdisciplinary doctoral network and an interdisciplinary group of PhD fellows, working alongside other researchers in the field.

DC8 Project

Multiplexed microarrays using new electrode-material for enhanced cancer screening

Description

The aim of this project is to develop novel nanocomposite polymer-based screen-printing inks and electrodes to act as platforms for electrocatalytic and ECL assays, for which the successful candidate will establish the data protocols for multiplexed assay data analysis in the Z&P DjuliTM cloud database. Anti-fouling properties of electrodes will be explored by micro- and nano-patterning and tested in industrial environment. Finally, analysis of multiplexed assay data in DjuliTM will be used as a pan-cancer screening tool.

Research field: Electrochemistry, Surface Science, Biochemistry, Molecular Biology

Main Supervisor(s): Sindre Søpstad (sindre@zimmerpeacock.com)

Host Institution:

Tuba Arif, M.Sc.

My name is Tuba Arif. I am from Pakistan, and I am pursuing a PhD at the University of Oslo in collaboration with Zimmer & Peacock AS. My fascination with biotechnology began in high school, where I quickly realized that creativity and innovation are at the heart of this discipline. I knew what I wanted to pursue in life. Creativity? Biotechnology! This passion led me to pursue a BS (Hon) in Biotechnology from the University of Veterinary and Animal Sciences in Lahore, Pakistan. In 2019, I was awarded the Türkiye Scholarship, which provided me the opportunity to seek an MS in Basic Biotechnology at Ankara University in Turkey. Cancer early detection and prevention has remained my priority as a researcher. A personal loss within my circle to late-stage diagnosis deeply motivated me to focus my research on developing portable, cost-effective, sensitive/efficient devices in the field of cancer diagnosis, reducing the public’s dependency on centralized healthcare and ensuring rapid diagnosis. My passion has driven me to work on a TÜBİTAK-funded project aimed at developing an electrochemical-based portable biosensor to detect lung cancer stem cell biomarkers. Additionally, I also developed a molecularly imprinted polymer-based electrochemical sensor to detect Ibrutinib in human for better treatment of chronic lymphocytic leukemia and mantle cell lymphoma, during my master’s degree. I am excited to be part of the STRIM Project and Zimmer & Peacock, collaborating with fellow scientists to develop innovative platforms that have the potential to revolutionize early multi-cancer detection.

DC9 Project

Understanding the social aspects of cancer screening to promote adoption

Description

The DC will apply the integrated stakeholder-centric impact evaluation framework to investigate expectations and requirements with respect to pan-cancer screening among all stakeholders (patients, payers and commissioners) involved in cancer screening. The DC start by mapping all relevant stakeholders, will collect user expectations and requirements with respect to pan-cancer screening and will elicit population preferences by making use of discrete choice experiments, focusing on the potential harms of pan-cancer screening (e.g. false-positive test results, overdiagnosis and complications), related to mortality reduction, test frequency and screening setting/location.

Research field: Health Sciences, Public Health, Epidemiology, Medicine.

Main Supervisor(s): Prof. Harry de Koning (h.dekoning@erasmusmc.nl) and Esther Toes-Zoutendijk (e.toes-zoutendijk@erasmusmc.nl)

Host Institution:

Kelma Jean, M.Sc.

Kelma is originally from Saint Lucia in the Caribbean. She earned a BSc in Medical Sciences at the University of Exeter in the UK, which nurtured her interest in Women’s Health research. She then completed three internships: as a research assistant on a perinatal mental health project at the University of Exeter, a Communications Intern at the scientific journal Sexual and Reproductive Health Matters (SRHM), and a Health Writer and Editor at Klarity, a health tech company. These experiences led her to pursue an MMSc in Global Health at Karolinska Institutet in Sweden, where she contributed to the ALERT research project in Tanzania for her thesis and later worked with them as a research assistant. She was also active in Synapse Sweden. After graduating, she joined the Nova Global Top Talent Network and worked at Alcimed in Germany as a Business Development Manager and Healthcare Consultant for pharmaceutical companies. Kelma is happy to have started her PhD at Erasmus MC as part of the STRIM Network, under the supervision of Esther Toes-Zoutendijk and Harry de Koning, and is looking forward to collaborating with all the other researchers. Her research will focus on understanding the social aspects of cancer screening, particularly related to patient preferences.

DC10 Project

HTA decision models for evaluation of harms, benefits and cost-effectiveness of cancer screening interventions

Description

The DC will evaluate the cost-effectiveness of different screening policy scenarios for pan-cancer approaches and will estimate the long-term benefits of screening and early detection (i.e. incidence and mortality reduction, quality-adjusted life-years gained). The DC will compare these outcomes to those of the existing cancer screening programs. In addition, the DC evaluates potential improvements to the pan-cancer test, and how these impact the comparative effectiveness of pan-cancer screening. This way, the DC can help define thresholds int test performance, acceptability and costs for pan-cancer screening to provide good value for money. For this, the DC will be trained in health technology assessment and microsimulation modeling for cancer screening.

Research field: Mathematics, Econometrics, Biostatistics.

Main Supervisor(s): Prof. dr. Iris Lansdorp-Vogelaar (i.vogelaar@erasmusmc.nl) and Esther Toes-Zoutendijk (e.toes-zoutendijk@erasmusmc.nl)

Host Institution:

Kay Rimalos, M.Sc.

My name is Kay, and I am originally from the Philippines. I earned my BSc in Applied Physics from the University of the Philippines – Manila and obtained my Master’s degree in Medical Physics at RMIT University in Australia. During my studies, I completed a radiotherapy medical physics internship and conducted a research project in collaboration with the Peter MacCallum Cancer Centre on radiotherapy treatment guidelines. These experiences sparked my interest in health research focused on supporting evidence-based policies and guidelines to improve cancer care and prevention. This interest led me to work as a Modelling Research Assistant at the Daffodil Centre and the University of Sydney. There, I contributed to microsimulation modelling projects evaluating the benefits, harms, and cost-effectiveness of cervical cancer screening strategies to inform health policies in high-income countries such as Australia, New Zealand, the US, and the UK. In May 2025, I began my PhD at Erasmus MC under the supervision of Prof. Iris Lansdorp-Vogelaar and Duco Mulder. My research focuses on microsimulation modelling and cost-effectiveness analysis of pan-cancer screening scenarios. I am excited to be part of the MSCA STRIM network, and I look forward to collaborating with others to explore the potential of emerging tools in cancer screening.

DC11 Project

Bioinformatic analyses to identify aberrant glycosylations and link them to clinical phenotypes

Description

The aim of this PhD project is the development of bioinformatic pipelines and molecular modeling approaches to analyzed glycoproteomics data produced during the projects by other collaborators or available in literature to identify suitable markers for aptamer design

Research field: Bioinformatics, Biochemistry, Molecular Modeling, Computational Biology.

Main Supervisor(s): Assoc. Prof. Elena Papaleo (elenap@cancer.dk)

Host Institution:

Beatrice Drago, M.Sc.

My name is Beatrice, and I am originally from Italy. I earned my Bachelor’s degree in Molecular Biology and my Master’s degree in Molecular Biotechnology at the University of Turin. During my studies, I first gained experience in a bioinformatics laboratory, where I worked on the computational analysis of genomic data. I later joined the Molecular Modelling for Drug Design group at the Department of Drug Science and Technology, where I carried out my Master’s thesis and subsequently held a post-graduate research fellowship. During this experience, I focused on molecular modelling and dynamics simulations applied to drug discovery, enhancing my understanding of protein structure and interactions. I have a strong interest in scientific research, molecular biology, and proteomics, and I am particularly motivated to integrate computational and experimental approaches to study biological systems at the molecular level.
As part of the STRIM PhD network, my project focuses on the molecular modelling of aberrant glycosylations and their role in cancer, aiming to identify and characterize glycoprotein targets suitable for aptamer-based recognition. I am excited to contribute to this interdisciplinary project to advance our understanding of PTMs in cancer and support the development of innovative diagnostic tools.

DC12 Project

A bioinformatic integrative framework to study aberrant glycosylation in the context of other biological data

Description

This PhD project aims to expand the Moonlight framework for integrative -omics analyses to support the analyses of glycoproteomics data and integrate them with other available quantitative biological data as gene expression, mutational data, methylation. Additionally, the project aims to include machine-learning solution to streamline the selection of the candidate markers using features from different quantitative data and clinical phenotypes. The DC will analyze data provided by other collaborators in the consortium or already available in public available repositories.

Research field: Bioinformatics, Biochemistry, Molecular Modeling, Computational Biology.

Main Supervisor(s): Assoc. Prof. Elena Papaleo (elenap@cancer.dk)

Host Institution:

Alessia Campo, M.Sc.

I’m Alessia and I am originally from Italy. In June 2025 I joined the Cancer Structural Biology Group in Copenhagen as a PhD student and as part of the STRIM Network. I hold a master’s degree in bioinformatics at the University of Bologna, and I have experience working as a bioinformatics software developer. My academic and professional background reflects a strong passion for using computational tools to study proteins and uncover the molecular mechanisms behind cancer. Over the next years, I will be working on integration of proteomics and glycoproteomic data within a computational framework developed by the CSB group- for the prediction of cancer driver genes and biomarkers. I will perform in-depth study of proteins aberrant PTMs and their role in cancer hallmarks. I’m eager to connect, collaborate, and learn from all the scientist part of this network and contribute to impactful research.

DC13 Project

Portable FET biosensor platform for NP-amplified multiplexed DNA sensing

Description

Main goal is to develop novel FET-based electronic measurements system for real-time potentometric and amperometric DNA detection. Important milestone is in the establishing of the bioreceptor functionalization, calibration and measurement formats for detection of methylated DNA of interest, using both, traditional molecular and nanoparticles-amplified formats. Finally, a demonstrator of the measurements system, enabling up to 102 pads monitored at the same time is expected.

Research field: Electrochemistry, Electronic biosensors, Electronic engineering, Materials Science.

Main Supervisor(s): Prof. Larysa Baraban (l.baraban@hzdr.de)

Host Institution:

Bogdana Đorđević, M.Sc

Bogdana joined STRIM as a part of the Department of Nano-Microsystems for Life Sciences at Helmholtz-Zentrum Dresden-Rossendorf (HZDR). She obtained both her MSc and BSc degrees in Electrical Engineering and Computing from School of Electrical Engineering at the University of Belgrade, Serbia and she also studied Electrochemical Engineering at the Faculty of Technology and Metallurgy at the University of Belgrade, Serbia. Her educational background is in semiconductors and sensors as well as materials and electrochemical methods. During her studies she was an undergraduate teaching assistant where she guided students through their practical laboratory assignments in courses Elements of Electronic Devices and Sensors and Actuators. Further, she was a junior associate at the Petnica Science Center where she organized daily activities of the Chemistry seminar for high school students, assessed their progress and guided them in the laboratory exercises and practice problems. She completed her master’s thesis in collaboration with the Group for biomedical engineering and nanobiotechnology at the Institute of Technical Sciences of Serbian Academy of Sciences and Arts, which is titled: Hydrothermal synthesis and characterization of chromium (III) oxide nanoparticles for applications in biomedicine. Additionally, during her master’s she did an internship at the Department of Nano-Microsystems for Life Sciences at HZDR, where she worked on developing flexible electrodes for in-vivo measurement of lactate.